[ET Net News Agency, 8 October 2018] Genscript Biotech (01548) said it repurchased
600,000 shares of the company on the Stock Exchange on 5 October 2018.
Up to 5 October 2018, the company has repurchased a total of 5.296 million of its own
shares. The company will subsequently cancel the repurchased shares. (SC)